Funding news
Insight Medbotics logo

Insight Medbotics Raises $37.2

Recently funded · $37.2M Series bHospitals and Health CareCAView source

Get the full Insight Medbotics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The push to transform prostate cancer care just got a significant boost, with Insight Medbotics announcing it has raised $37.2M in Series b funding. The company is building the first MRI-native platform for prostate cancer biopsy and treatment, aiming to provide urologists with a more accurate way to identify and target lesions.

Its Glenn™ platform, which includes an MRI-compatible robot, is the only one to receive FDA 510(k) clearance for use of a robot with MRI, positioning Insight Medbotics to advance the standard of care.

Other Canada companies recently funded

View all

Biggest recent Robotics rounds

Largest funding rounds in Robotics on Signalbase right now.

#CompanyAmount
1
AIDIN ROBOTICS logo

AIDIN ROBOTICS

China

$15.0B
2
AGIBOT logo

AGIBOT

China

$6.0B
3
Figure logo

Figure

United States

$3.2B
4
Bedestrian logo

Bedestrian

United States

$2.1B
5
Lumentum logo

Lumentum

United States

$2.0B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Solarscale (US) logo

Solarscale (US)

United States

$21.3M
2
BioSim Innovations logo

BioSim Innovations

United States

$22.3M
3
Neuralink logo

Neuralink

United States

$28.7M
4
SolarTech Fotovoltaice logo

SolarTech Fotovoltaice

Romania

$35.0M
5
BioTechX logo

BioTechX

Switzerland

$45.0M